Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Pharmacology Research & Perspectives|December 16, 2014
Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury painAldric T Hama, James P Pearson, Jacqueline SagenNeuropharmacology|December 9, 2014
Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathyFarinaz Nasirinezhad, Stanislava Jergova, James P Pearson, et al.Plos One|May 3, 2014
Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury painAldric T Hama, Peter Germano, Matthew S Varghese, et al.Neurogastroenterology and Motility|September 30, 2024
FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF1 agonist mediated visceral hypersensitivity in male ratsMuriel Larauche, Agata Mulak, Chrysanthy Ha, et al.The Journal of Pharmacology and Experimental Therapeutics|October 23, 2010
Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's diseaseTom H Johnston, Philippe Huot, Susan H Fox, et al.Pageof 1